Type I interferons and the innate immune response--more than just antiviral cytokines.
暂无分享,去创建一个
[1] M. Arditi,et al. Cooperation of Toll-Like Receptor 2 and 6 for Cellular Activation by Soluble Tuberculosis Factor and Borrelia burgdorferi Outer Surface Protein A Lipoprotein: Role of Toll-Interacting Protein and IL-1 Receptor Signaling Molecules in Toll-Like Receptor 2 Signaling1 , 2001, The Journal of Immunology.
[2] T. Mak,et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4 , 2002, Nature.
[3] S. Gupta,et al. IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells. , 1999, Journal of immunology.
[4] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[5] E. Kopp. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts , 2004 .
[6] E. Coccia,et al. Viral infection and Toll‐like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte‐derived dendritic cells , 2004, European journal of immunology.
[7] Jongdae Lee,et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[8] H. Klenk,et al. The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3 , 2003, Journal of Virology.
[9] S. Dower,et al. Toll-Like Receptors in Health and Disease: Complex Questions Remain1 , 2003, The Journal of Immunology.
[10] S. Roy,et al. Interleukin-6 modulates interferon-regulated gene expression by inducing the ISGF3γ gene using CCAAT/enhancer binding protein-beta (C/EBP-β) , 2000 .
[11] C. Walker,et al. Toll-like receptors as potential therapeutic targets for multiple diseases , 2002, Nature Reviews Drug Discovery.
[12] N. Kadowaki,et al. Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens , 2001, The Journal of experimental medicine.
[13] J. Lindenmann,et al. Virus interference. I. The interferon , 1957, Proceedings of the Royal Society of London. Series B - Biological Sciences.
[14] H. Iwasaki,et al. CpG‐DNA‐induced IFN‐α production involves p38 MAPK‐dependent STAT1 phosphorylation in human plasmacytoid dendritic cell precursors , 2002, Journal of leukocyte biology.
[15] L. Pfeffer. Biologic activities of natural and synthetic type I interferons. , 1997, Seminars in oncology.
[16] Douglas T. Golenbock,et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus , 2000, Nature Immunology.
[17] P. Kontsek. Human type I interferons: structure and function. , 1994, Acta virologica.
[18] S. Akira,et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.
[19] R. Everett,et al. The Herpes Simplex Virus ICP0 RING Finger Domain Inhibits IRF3- and IRF7-Mediated Activation of Interferon-Stimulated Genes , 2004, Journal of Virology.
[20] M. Heim. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus. , 1999, Journal of receptor and signal transduction research.
[21] J. Darnell,et al. Role of STAT2 in the alpha interferon signaling pathway , 1995, Molecular and cellular biology.
[22] K. Anderson,et al. A conserved signaling pathway: the Drosophila toll-dorsal pathway. , 1996, Annual review of cell and developmental biology.
[23] Paul J Hertzog,et al. The interferon in TLR signaling: more than just antiviral. , 2003, Trends in immunology.
[24] M. Greenblatt,et al. A Toll-like Receptor That Prevents Infection by Uropathogenic Bacteria , 2004, Science.
[25] D. Levy,et al. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock , 2003, Nature Immunology.
[26] G. Stark,et al. SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling , 2003, Nature Immunology.
[27] D. Kalvakolanu,et al. Inositol Hexakisphosphate Kinase 2 Mediates Growth Suppressive and Apoptotic Effects of Interferon-β in Ovarian Carcinoma Cells* , 2001, The Journal of Biological Chemistry.
[28] Stanley M. Lemon,et al. Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease , 2003, Science.
[29] V. A. Stewart,et al. Malaria Blood Stage Parasites Activate Human Plasmacytoid Dendritic Cells and Murine Dendritic Cells through a Toll-Like Receptor 9-Dependent Pathway1 , 2004, The Journal of Immunology.
[30] S. Akira,et al. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] T. Fujita,et al. TIR-containing Adapter Molecule (TICAM)-2, a Bridging Adapter Recruiting to Toll-like Receptor 4 TICAM-1 That Induces Interferon-β* , 2003, Journal of Biological Chemistry.
[32] Sankar Ghosh,et al. Negative Regulation of Toll-like Receptor-mediated Signaling by Tollip* , 2002, The Journal of Biological Chemistry.
[33] C. Janeway,et al. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity , 1997, Nature.
[34] M. J. Cody,et al. TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages , 2002, Nature Immunology.
[35] T. Maniatis,et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway , 2003, Nature Immunology.
[36] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[37] B. Williams,et al. Poly(dI·dC)-induced Toll-like Receptor 3 (TLR3)-mediated Activation of NFκB and MAP Kinase Is through an Interleukin-1 Receptor-associated Kinase (IRAK)-independent Pathway Employing the Signaling Components TLR3-TRAF6-TAK1-TAB2-PKR* , 2003, The Journal of Biological Chemistry.
[38] G. Schütz,et al. Lipopolysaccharide and ceramide docking to CD14 provokes ligand‐specific receptor clustering in rafts , 2001, European journal of immunology.
[39] S. Constantinescu,et al. Complementation of the interferon alpha response in resistant cells by expression of the cloned subunit of the interferon alpha receptor. A central role of this subunit in interferon alpha signaling. , 1994, The Journal of biological chemistry.
[40] S. Akira,et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5 , 2001, Nature.
[41] J. Hoffmann,et al. Toll signaling: the TIReless quest for specificity , 2003, Nature Immunology.
[42] Shizuo Akira,et al. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.
[43] E. Fikrig,et al. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice , 2002, Nature Medicine.
[44] P. Ricciardi-Castagnoli,et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.
[45] S. Constantinescu,et al. Direct Association of STAT3 with the IFNAR-1 Chain of the Human Type I Interferon Receptor (*) , 1996, The Journal of Biological Chemistry.
[46] T. Akazawa,et al. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β induction , 2003, Nature Immunology.
[47] Ryan M. O’Connell,et al. Toll-Like Receptor 3 Mediates a More Potent Antiviral Response Than Toll-Like Receptor 41 , 2003, The Journal of Immunology.
[48] S. Akira,et al. Toll-like Receptors and Their Signaling Mechanisms , 2003, Scandinavian journal of infectious diseases.
[49] T. Maniatis,et al. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[50] S. Akira,et al. Unresponsiveness of MyD88-deficient mice to endotoxin. , 1999, Immunity.
[51] F. Inagaki,et al. Identification of Ser-386 of Interferon Regulatory Factor 3 as Critical Target for Inducible Phosphorylation That Determines Activation* , 2004, Journal of Biological Chemistry.
[52] T. Taniguchi,et al. Regulation of IFN‐α/β genes: evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN‐α/β , 1996, Genes to cells : devoted to molecular & cellular mechanisms.
[53] M. Fellous,et al. A protein tyrosine kinase in the interferon α β signaling pathway , 1992, Cell.
[54] S. Akira,et al. Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells , 2003, The Journal of experimental medicine.
[55] S. Akira,et al. Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway , 2003, Science.
[56] J. Hiscott,et al. Transcriptional Profiling of Interferon Regulatory Factor 3 Target Genes: Direct Involvement in the Regulation of Interferon-Stimulated Genes , 2002, Journal of Virology.
[57] Gerard J. Nau,et al. Cumulative Toll-Like Receptor Activation in Human Macrophages Treated with Whole Bacteria1 , 2003, The Journal of Immunology.
[58] R. Ransohoff,et al. Catalytically Active TYK2 Is Essential for Interferon-β-mediated Phosphorylation of STAT3 and Interferon-α Receptor-1 (IFNAR-1) but Not for Activation of Phosphoinositol 3-Kinase* , 1999, The Journal of Biological Chemistry.
[59] M. Karin,et al. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4 , 2004, Nature.
[60] Shizuo Akira,et al. Toll/IL-1 Receptor Domain-Containing Adaptor Inducing IFN-β (TRIF) Associates with TNF Receptor-Associated Factor 6 and TANK-Binding Kinase 1, and Activates Two Distinct Transcription Factors, NF-κB and IFN-Regulatory Factor-3, in the Toll-Like Receptor Signaling 1 , 2003, The Journal of Immunology.
[61] S. Goodbourn,et al. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. , 2000, The Journal of general virology.
[62] A. Schattner,et al. Terminal differentiation of myeloleukemic M1 cells induced by IL-6: role of endogenous interferon. , 1991, Lymphokine and cytokine research.
[63] J. Hiscott,et al. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[64] Scott R. Presnell,et al. IL-28, IL-29 and their class II cytokine receptor IL-28R , 2002, Nature Immunology.
[65] D. Lejeune,et al. Cloning of a new type II cytokine receptor activating signal transducer and activator of transcription (STAT)1, STAT2 and STAT3. , 2003, The Biochemical journal.
[66] P. Fallon,et al. Primitive Toll signalling: bugs, flies, worms and man. , 2001, Trends in immunology.
[67] E. Coccia,et al. Selective Expression of Type I IFN Genes in Human Dendritic Cells Infected with Mycobacterium tuberculosis1 , 2002, The Journal of Immunology.
[68] Jiahuai Han,et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling , 2003, Nature.
[69] D. Olive,et al. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. , 2003, Journal of immunology.
[70] J. Dai,et al. Comparative analysis of IRF and IFN‐alpha expression in human plasmacytoid and monocyte‐derived dendritic cells , 2003, Journal of leukocyte biology.
[71] Daniel R. Caffrey,et al. LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF , 2003, The Journal of experimental medicine.
[72] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[73] S. Akira,et al. Interferon-α and Interleukin-12 Are Induced Differentially by Toll-like Receptor 7 Ligands in Human Blood Dendritic Cell Subsets , 2002, The Journal of experimental medicine.
[74] S. Ross,et al. Murine retroviruses activate B cells via interaction with toll-like receptor 4 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[75] A. Lewis-Antes,et al. IFN-λs mediate antiviral protection through a distinct class II cytokine receptor complex , 2003, Nature Immunology.
[76] R. Buller,et al. Vaccinia Virus B18R Gene Encodes a Type I Interferon-binding Protein That Blocks Interferon α Transmembrane Signaling (*) , 1995, The Journal of Biological Chemistry.
[77] P. Pitha,et al. On the role of IRF in host defense. , 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[78] S. Akira,et al. Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1 , 2002, The Journal of Immunology.
[79] S. Akira,et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4 , 2002, Nature.
[80] Govinda Rao,et al. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. , 2002, Immunity.
[81] Charles H. Lin,et al. Transcriptional activity of interferon regulatory factor (IRF)-3 depends on multiple protein-protein interactions. , 2002, European journal of biochemistry.
[82] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[83] B. Cohen,et al. The human interferon α β receptor: Characterization and molecular cloning , 1994, Cell.
[84] K. Csiszȧr,et al. A novel human gene (SARM) at chromosome 17q11 encodes a protein with a SAM motif and structural similarity to Armadillo/beta-catenin that is conserved in mouse, Drosophila, and Caenorhabditis elegans. , 2001, Genomics.